Integra LifeSciences reported Q3 2026 revenues of $411.2 million, up 2.3% year-over-year, despite a $7 million revenue hit from flood damage at its Cincinnati facility. GAAP earnings per share improved to $0.19 from a loss of $0.07 last year, with adjusted EPS at $0.59, beating prior year’s $0.54. The company generated $96 million in operating cash flow and completed a $2.1 billion debt refinancing to extend maturities and improve financial flexibility. Guidance for full-year 2026 remains steady, with revenues expected between $1.634 billion and $1.654 billion and adjusted EPS of $2.30 to $2.40, reflecting ongoing recovery efforts and cautious outlook for Tissue Reconstruction segment.
Integra LifeSciences' Q3 2026 financial results provide context for health sector performance on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 21, 2026 16:02 WIB: Among 150 priced health-sector US stocks, 73 rose and 66 fell. Danaher Corporation (DHR) traded at USD 220.49 with a 1-day change of -1.57% and a Pluang order activity skewed 79% Sell / 21% Buy, while Heron Therapeutics Inc (HRTX) was priced at USD 0.36, up 1.55%, with a more balanced order activity of 48% Sell / 52% Buy. Abbott Laboratories (ABT) stood at USD 101.12, down 1.53%, with a higher buy interest at 67% Buy versus 33% Sell and a typical hold time of 96 days on Pluang.
The Human Feedback Foundation, supported by RBC, has launched the Agentic AI Design Exchange, a national program aimed at helping Canadian nonprofits design, build, and deploy AI agents responsibly. Funded through RBC's Stronger Nonprofits Program, t...
Satellos Bioscience Inc., a clinical-stage company focused on treatments for degenerative muscle diseases, announced its management will participate in two investor conferences in November: the Guggenheim Healthcare Innovation Conference on Nov 9 in ...
YYForce Inc. has purchased 20 wearable data collection systems to gather real task data from hotel room service at Novotel Singapore. This project aims to record and analyze experienced staff performing tasks like bed-making, towel folding, and clean...
The global digital health and remote patient monitoring market is projected to grow from $26.8 billion in 2025 to $80.8 billion by 2031, at a compound annual growth rate of 20.2%. This growth is driven by increasing demand for chronic disease managem...
The global private credit and alternative lending market, valued at $2.31 trillion in 2026, is expected to grow at a 7.8% CAGR to reach $3.36 trillion by 2031. Recent liquidity pressures in 2025, triggered by bankruptcies and AI sector concerns, caus...
